Deltex Medical eyes accelerated second half growth

9th Jul 2013 10:47

Deltex Medical said half year sales fell from the same period a year earlier but it expects to deliver accelerated growth over and above current levels as programmes start to come through in the second half of the year. The group, which provides blood flow monitors during and after operations, said sales fell to £2.9m in the six months ended June 30th compared with £3.2m a year earlier as increases in high margin probe sales offset by a decrease in low margin monitor sales. Deltex saw strong growth in surgical probe revenues. In the UK sales were up 14% on the prior year and has seen over 30% growth in second quarter since start of NHS implementation drive. US revenue rose 17% from the year before as its pipeline. International revenue was marginally ahead while France was up over 20%. Chairman Nigel Keen commented: "We entered 2013 with traction established in many of our major target markets and have maintained this momentum in the year to date. Major developments in the first half include: the start of the UK's implementation drive for intra-operative fluid management; the granting of an ODM specific physician payment code and the start of the Premier collaboration in the USA; and the publication of clinical guidelines for fluid management in France." "As the benefits of each of these programmes start to come through in the second half of the year, we expect to deliver accelerated growth over and above current levels." CJ